Prevalence of Acute Critical Neurological Disease in Children: a Global Epidemiological Assessment

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

922 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-11-30

Study Completion Date

2014-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

PANGEA is an international prospective point prevalence study to describe the epidemiology, interventions, and outcomes in children with acute critical brain disease.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Characterizing the Effect of Dopamine on Markers of Lymph Re-circulation in Fontan-associated Protein-losing Enteropathy

NCT03322345

Dopamine Protein-Losing Enteropathies Lymphatic System +4 more

ENROLLING_BY_INVITATION

Research a New Predictive Marker of Intraventricular Hemorrhage in Very Preterm Infants

NCT02400853

Intraventricular Hemorrhage

COMPLETED NA

Contrast Enhanced Ultrasound Evaluation of Brain Perfusion in Neonatal Post-Hemorrhagic Hydrocephalus

NCT03061045

Neonatal Post-Hemorrhagic Hydrocephalus

WITHDRAWN PHASE4

Neuroimaging and Neuromonitoring in Critically Ill Children With Sepsis

NCT03055455

Septic Shock

COMPLETED

Ultrasonographic Prognostic Scale of Periventricular Hemorrhagic Infarction

NCT05918016

Preterms Infarction Cerebral

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiac Arrest Stroke Traumatic Brain Injury Brain Mass Status Epilepticus Spinal Cord Disease Hydrocephalus

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

CROSS_SECTIONAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

No intervention

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Children aged 7 days to 17 years inclusively and admitted to an ICU (ICU can be classified as general, cardiac, trauma, etc).
2. Children with acute or acute on chronic neurologic disease that occurred just prior to hospital admission or occurred during the hospital admission.
3. Acute neurologic disease is secondary to TBI, stroke, brain mass, hydrocephalus, cardiac arrest, status epilepticus, CNS infection/inflammation, or spinal cord injury.